Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction
Changdong Lin(Center for Excellence in Molecular Cell Science), Jianfeng Chen(Shanghai Normal University), Yuebin Zhang(Liaoning Normal University), Guohui Li(University of Science and Technology of China), Jing Liu(Tianjin University of Traditional Chinese Medicine), Yue Li(Longgang Central Hospital), Chenjian Gu(Washington University in St. Louis), Yutang Li(Shanghai Medical College of Fudan University), Xia Mu(Dalian Institute of Chemical Physics), Zhaoyuan Liu(Hangzhou Dianzi University)
Cited by 50
Related Papers
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction
|Circulation Research|2022|532
Modular Pathway Engineering of Diterpenoid Synthases and the Mevalonic Acid Pathway for Miltiradiene Production
|Journal of the American Chemical Society|2012|410
Deterministic reprogramming of neutrophils within tumors
|Science|2024|347
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332